Health Care [ 3/12 ] | Biotechnology [ 26/73 ]
NASDAQ | Common Stock
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.
The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprising instruments, consumables, and software analysis.
It also offers proteome analysis system, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent probe binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples.
In addition, the company offers reagent kits, which include sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs.
Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jul 31, 25 | -0.12 Increased by +14.29% | -0.15 Increased by +20.00% |
| Apr 29, 25 | -0.13 Increased by +13.33% | -0.15 Increased by +13.33% |
| Feb 27, 25 | -0.14 Increased by 0.00% | -0.15 Increased by +6.67% |
| Oct 29, 24 | -0.13 Increased by 0.00% | -0.17 Increased by +23.53% |
| Jul 30, 24 | -0.14 Decreased by -7.69% | -0.16 Increased by +12.50% |
| Apr 30, 24 | -0.15 Decreased by -25.00% | -0.16 Increased by +6.25% |
| Feb 28, 24 | -0.14 Decreased by -27.27% | -0.14 |
| Oct 31, 23 | -0.13 Decreased by -18.18% | -0.17 Increased by +23.53% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 0.00 Decreased by N/A% | -15.03 M Increased by +16.53% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -16.61 M Increased by +11.30% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by -100.00% | -17.59 M Decreased by -3.35% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -16.45 M Decreased by -3.58% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -18.01 M Decreased by -13.93% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -18.73 M Decreased by -25.16% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 8.21 M Increased by +N/A% | -17.02 M Decreased by -26.96% | Decreased by -207.31% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -15.88 M Decreased by -12.91% | Decreased by N/A% Decreased by N/A% |